What is Hims?
Founded in 2017 and headquartered in San Francisco, Hims & Hers Health, Inc. operates a sophisticated direct-to-consumer digital platform that bridges the gap between patients and licensed healthcare professionals. By leveraging a multi-specialty approach, the company provides comprehensive consultations and personalized treatment plans for conditions ranging from dermatology and mental health to weight management and hormone health.
The company's market position is defined by its seamless integration of prescription medications, over-the-counter products, and laboratory testing services. By utilizing machine learning to refine patient outcomes, Hims & Hers has successfully disrupted traditional healthcare delivery models, establishing a significant presence on the New York Stock Exchange and maintaining operations across North America and Europe.
How much funding has Hims raised?
Hims has raised a total of $457M across 3 funding rounds:
Other Financing Round
$7M
Other Financing Round
$50M
Debt
$400M
Other Financing Round (2017): $7M with participation from Forerunner Ventures, Harrys, Amity Supply, Cherubic Ventures, SV Angel, Maverick Capital, and Thrive Capital
Other Financing Round (2018): $50M led by Thrive Capital, Forerunner Ventures, Redpoint Ventures, and Institutional Venture Partners
Debt (2026): $400M supported by JPMorgan Chase
Key Investors in Hims
JPMorgan Chase
A leading global financial services firm providing comprehensive investment banking and commercial banking solutions to support large-scale corporate growth.
Thrive Capital
A New York-based venture capital firm specializing in internet and software investments, known for backing high-growth technology companies.
Forerunner Ventures
A venture firm focused on the intersection of technology and human behavior, partnering with founders to build category-defining consumer brands.
What's next for Hims?
Looking ahead, the infusion of $400M positions Hims & Hers to accelerate its strategic roadmap, focusing on the deepening of its AI-driven diagnostic capabilities and the broadening of its retail partnership network. As the company navigates the complexities of the global telehealth landscape, this capital will likely be deployed to enhance patient acquisition efficiency and diversify its product portfolio in high-growth wellness categories.
The firm's ability to maintain its consumer-first ethos while scaling enterprise-level operations remains a key indicator of its long-term viability. With a strong foundation of institutional backing, Hims & Hers is well-equipped to address evolving healthcare demands and sustain its competitive advantage in the digital wellness ecosystem.
